ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,399.22
-0.51%
Dow Jones
39,935.07
0.20%
US Dollar vs MXN
18.46194
0.53%
Brent Oil
81.535
0.99%
Bitcoin
65,704.98
0.51%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. USOTC
  6. Bionik Laboratories Corporation (CE) (BNKL)

  7. Bionik Laboratories Corporation (CE) (BNKL) Noticias

BNKL

Bionik Laboratories (CE) (BNKL)

Bionik Laboratories Corporation (CE)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:USOTC:BNKL
FechaHoraFuenteTítuloSímboloCompañía
30/06/202315:31Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]USOTC:BNKLBionik Laboratories Corporation (CE)
21/06/202316:05Edgar (US Regulatory)Annual Report (10-k)USOTC:BNKLBionik Laboratories Corporation (CE)
21/06/202309:59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:BNKLBionik Laboratories Corporation (CE)
16/06/202307:56Edgar (US Regulatory)Current Report Filing (8-k)USOTC:BNKLBionik Laboratories Corporation (CE)
08/02/202307:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:BNKLBionik Laboratories Corporation (CE)
07/12/202210:29Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:BNKLBionik Laboratories Corporation (CE)
07/12/202210:27Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:BNKLBionik Laboratories Corporation (CE)
04/11/202215:32Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:BNKLBionik Laboratories Corporation (CE)
25/10/202210:28Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:BNKLBionik Laboratories Corporation (CE)
27/05/202212:31Edgar (US Regulatory)Confidential Treatment Order (ct Order)USOTC:BNKLBionik Laboratories Corporation (CE)
01/06/202013:17Edgar (US Regulatory)Specialized Disclosure Report (sd)USOTC:BNKLBionik Laboratories Corporation (CE)
21/02/202016:12Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:BNKLBionik Laboratories Corporation (CE)
13/02/202011:17Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:BNKLBionik Laboratories Corporation (CE)
13/11/201905:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:BNKLBionik Laboratories Corporation (CE)
12/11/201914:58Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:BNKLBionik Laboratories Corporation (CE)
28/10/201909:05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:BNKLBionik Laboratories Corporation (CE)
16/09/201916:26Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:BNKLBionik Laboratories Corporation (CE)
18/03/201905:05Edgar (US Regulatory)Withdrawal of Registration Statement (rw)USOTC:BNKLBionik Laboratories Corporation (CE)
11/02/201915:21Edgar (US Regulatory)Seperately Filed Delaying Amendment Under Securities Act Rule 473 to Delay Effectiveness of a 1933 Act Registration Statement...USOTC:BNKLBionik Laboratories Corporation (CE)
16/10/201816:24Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:BNKLBionik Laboratories Corporation (CE)
17/08/201816:15Edgar (US Regulatory)Information Statement - All Other (definitive) (def 14c)USOTC:BNKLBionik Laboratories Corporation (CE)
10/08/201816:11Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:BNKLBionik Laboratories Corporation (CE)
07/08/201816:36Edgar (US Regulatory)Proxy Statement - Other Information (preliminary) (pre 14c)USOTC:BNKLBionik Laboratories Corporation (CE)
15/06/201813:38Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)USOTC:BNKLBionik Laboratories Corporation (CE)
05/10/201716:27Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)USOTC:BNKLBionik Laboratories Corporation (CE)
05/10/201713:30Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)USOTC:BNKLBionik Laboratories Corporation (CE)
03/08/201716:29Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:BNKLBionik Laboratories Corporation (CE)
14/07/201716:29Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)USOTC:BNKLBionik Laboratories Corporation (CE)
12/07/201715:27Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:BNKLBionik Laboratories Corporation (CE)
30/06/201716:08Edgar (US Regulatory)Amended Tender Offer Statement by Issuer (sc To-i/a)USOTC:BNKLBionik Laboratories Corporation (CE)
 Showing the most relevant articles for your search:USOTC:BNKL

Su Consulta Reciente

NYSE
XOM
Exxon Mobil
NYSE
DIS
Walt Disney
FX
EURUSD
Euro vs US Dollar
COIN
BTCUSD
Bitcoin
AMEX
XLF
Financial Select Sector
NYSE
NKE
Nike
USI
USTECH100
US Tech 100
COIN
SOLUSD
Solana
AMEX
XLE
Energy Select Sector SPDR
NYSE
KO
Coca Cola
NASDAQ
GOOGL
Alphabet
USOTC
BASFY
BASF (QX)
NASDAQ
MSFT
Microsoft
NYSE
AXP
American Express
NYSE
VZ
Verizon Communications
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados